Progesterone Receptor anticorps (pSer294)
Aperçu rapide pour Progesterone Receptor anticorps (pSer294) (ABIN371835)
Antigène
Voir toutes Progesterone Receptor (PGR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- pSer294
-
Specificité
- This antibody is specific for the ~90k PR-A isoform and the ~120k PR-B isoform phosphorylated at Ser294. Immunolabeling is blocked by the phosphopeptide used as the antigen but not by the corresponding dephosphopeptide.
-
Réactivité croisée (Details)
-
Species reactivity (expected):Mouse, Rat and non-Human Primates.
Species reactivity (tested):Human. -
Attributs du produit
- Synonyms: PR, PGR, NR3C3, Nuclear Receptor Subfamily 3 Group C Member 3
-
Purification
- Affinity Chromatography on Protein G.
-
Immunogène
- Phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser294of Human progesterone receptor.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
-
Western Blot: 1/1000. Immunohistochemitry (Frozen Sections, unpublished observations): 1/1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg/mL BSA and 50 % Glycerol.
-
Stock
- -20 °C
-
Stockage commentaire
-
Store the antibody undiluted (in aliquots) at -20 °C. Avoid repeated freezing and thawing.
Shelf life: one year from despatch. -
Date de péremption
- 12 months
-
-
- Progesterone Receptor (PGR)
-
Autre désignation
- Progesterone Receptor
-
Sujet
- There is accumulating evidence to suggest that progesterone plays an essential role in the regulation of growth and differentiation of mammary glands and thus may play a key role in breast cancer (Edwards, 2005). The biological response to progesterone is mediated by two distinct forms of the human progesterone receptor (PR-A and PR-B forms). In most cell contexts, the B form functions as a transcriptional activator, whereas the A form functions as a transcriptional inhibitor of steroid hormones (Attia et al., 2000, Lin et al., 2003). Recently it has been demonstrated that there is differential hormone dependent regulation of the phosphorylation of the A and B forms of the receptor (Clemm et al., 2000) . Treatment of T47D breast cancer cells with progestin agonist increases the phosphorylation of Ser190 and Ser294 with different kinetics. These phosphorylation events may differentially affect the transcriptional activity of the receptor.Synonyms: NR3C3, Nuclear Receptor Subfamily 3 Group C Member 3, PGR, PR
-
ID gène
- 5241
-
UniProt
- P06401
-
Pathways
- Nuclear Receptor Transcription Pathway, Intracellular Steroid Hormone Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway, Smooth Muscle Cell Migration
Antigène
-